Legal & General Group PLC Spring Works Therapeutics, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 65,765 shares of SWTX stock, worth $3.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,765

Previous 64,668 1.7%

Holding current value

$3.83 Million

Previous $2.07 Million 14.73%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$28.61 - $42.55 $31,385 - $46,677	1,097 Added 1.7%	65,765 $2.38 Million
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $38,415 - $51,269	1,199 Added 1.89%	64,668 $2.07 Million
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $456,375 - $602,678	12,656 Added 24.91%	63,469 $2.39 Million
Q1 2024 May 14, 2024	BUY	$36.5 - $52.5 $41,756 - $60,060	1,144 Added 2.3%	50,813 $2.5 Million
Q4 2023 Feb 15, 2024	BUY	$18.94 - $37.24 $228,321 - $448,928	12,055 Added 32.05%	49,669 $1.81 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $10,103 - $13,713	-437 Reduced 1.15%	37,614 $869,000
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $98,156 - $138,690	4,240 Added 12.54%	38,051 $997,000
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $229,474 - $312,919	9,190 Added 37.33%	33,811 $870,000
Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $49,414 - $65,309	-2,274 Reduced 8.46%	24,621 $640,000
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $36,969 - $60,838	-1,534 Reduced 5.4%	26,895 $767,000
Q2 2022 Aug 22, 2022	BUY	$18.36 - $60.07 $122,277 - $400,066	6,660 Added 30.59%	28,429 $700,000
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $146 - $196	3 Added 0.01%	21,769 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $2,718 - $3,867	51 Added 0.23%	21,766 $1.35 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $239,925 - $337,947	3,829 Added 21.41%	21,715 $1.38 Million
Q2 2021 Aug 12, 2021	BUY	$67.45 - $85.63 $250,914 - $318,543	3,720 Added 26.26%	17,886 $1.47 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $692,338 - $995,329	10,635 Added 301.19%	14,166 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $20,214 - $32,570	418 Added 13.43%	3,531 $256,000
Q3 2020 Nov 13, 2020	SELL	$36.14 - $51.99 $33,827 - $48,662	-936 Reduced 23.12%	3,113 $148,000
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $57,633 - $121,813	2,508 Added 162.75%	4,049 $170,000
Q1 2020 May 14, 2020	SELL	$20.44 - $41.21 $476,865 - $961,429	-23,330 Reduced 93.8%	1,541 $41,000
Q4 2019 Feb 13, 2020	BUY	$17.74 - $39.52 $437,752 - $975,195	24,676 Added 12654.36%	24,871 $954,000
Q3 2019 Nov 13, 2019	BUY	$18.8 - $27.82 $3,666 - $5,424	195 New	195 $4,000

Others Institutions Holding SWTX

# of Institutions

236

Shares Held

67.2M

Call Options Held

260K

Put Options Held

316K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.63B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Spring Works Therapeutics, Inc. Transaction History